Severely ill ELA (ALS) patients in Andalusia remain without the financial support approved nationally. Months after the state agreement, the regional government has yet to deliver payments. Families report repeated attempts to obtain assistance, with some waiting since April as the disease progresses. Many feel abandoned by the system, while daily care needs become overwhelming and unaffordable without external help.
The delay affects dozens of applicants across the region, even though the Council of Social Services established the aid pathway nearly nine months ago and set eligibility criteria eight months ago. The promised monthly support ranges from €3,200 to €9,850, but no patient in Andalusia has received funds so far. ELA Andalucía says the regional government recently contacted a handful of families, who expect payment soon. The majority remain in limbo.
Andalusia shares this backlog with other regions. Information from the national confederation ConELA, similar delays have been reported in Aragón and Navarra, as well as the Canary Islands, the Balearic Islands and Murcia. The administrative process is described as burdensome: families must submit extensive documentation and endure long waits. That has fueled frustration and uncertainty about whether payments will be made retroactively.
Spain has around 4,000 ELA patients, with approximately 750 in Andalusia. Following a unanimous vote in Congress, €500 million was allocated to support people with the most severe forms of the disease. The Ministry of Social Rights provides €4,930 per patient each month, while regions are expected to supplement the rest. Some regions, including Catalonia and La Rioja, as well as Navarra, have set higher aid ceilings. ConELA estimates that 24-hour care costs €14,000 to €18,000 per month.
The Andalusian government says it has started processing payments but has not disclosed how many patients have benefited or the average amount granted. Officials cite the lengthy development of the national law and note that Andalusia introduced its own temporary aid in June 2025. The program resolved nearly 190 applications and distributed over €2.3 million. These regional grants, capped at €14,400 annually, fall far short of the estimated minimum care costs for the most severe cases.
Administrative bottlenecks persist, particularly in linking financial aid to home care services. Challenges include finding accredited providers and securing specialized staff, alongside contract oversight. The government reports 54 resolved cases but acknowledges ongoing obstacles to delivering payments effectively.
ConELA criticizes the slow pace in Andalusia and five other regions, stressing that time is critical for patients whose condition can deteriorate rapidly. Some communities, including Valencia and Castilla y León, have accelerated their response, but Andalusia has yet to confirm any completed payments. The confederation says 20% to 30% of the most severely affected patients ultimately request euthanasia, unable to cope with the lack of support and the high cost of care.
To qualify for the highest level of aid, grade III+, ELA patients must meet strict criteria, including advanced immobility and dependence on ventilatory support. The law allows for a means-tested copayment that can reduce the maximum subsidy by up to 40%, based on family income. Madrid initially announced such a copayment, then reversed the decision after public backlash.
Caregivers highlight the strain on families, noting that hospitalizations for these patients often cost more than home care. The system requires families to act as employers when hiring caregivers, adding another layer of complexity. Other regions also face healthcare pressures, as seen when Ceuta’s health services faced severe pressure following a sudden influx of migrants.
Spain’s approach to ELA care is shaped by the 2006 Dependency Law, which aims to guarantee support for people with severe disabilities. Yet the gap between legal rights and practical access remains wide, especially in regions where administrative delays persist. In Andalusia, those delays continue to impede timely assistance for the most vulnerable patients.
